In both mice and humans, BRB disruption is associated with a more advanced DR stage (1), and CCL2 levels are increased in patients with DR and correlate with diabetic macular edema (23), a marked cause of vision loss in patients with DR. This evidence concerns the gene CCL2 and diabetic macular edema.